Cite

HARVARD Citation

    Briceño, D. et al. (n.d.). Thromboembolic and bleeding risks in patients undergoing atrial fibrillation ablation: oral anticoagulation perspectives. Expert opinion on drug safety. 16 (7), pp. 769-777. [Online]. 
  
Back to record